Borer, Jeffrey S.
SUNY Downstate Health Sciences University · Cornell University · Weill Cornell Medicine
14 papers on CoChatORCID 0000-0001-9917-2141
Most cited papers
- Verified
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
Swedberg, K., Komajda, M., Böhm, M., Borer, J. S., Ford, I., Dubost-Brama, A., Lerebours, G., & Tavazzi, L. (2010) · The Lancet
Heart rate and cardiovascular healthHeart Failure Treatment and Management
Cited by 2,563
- Verified
Targeted Anticytokine Therapy in Patients With Chronic Heart Failure: Results of the Randomized Etanercept Worldwide Evaluation (RENEWAL)
Mann, D. L., McMurray, J. J. V., Packer, M., Swedberg, K., Borer, J. S., Colucci, W. S., Djian, J., Drexler, H., Feldman, A., Kober, L., et al. (2004) · Circulation
Heart Failure Treatment and ManagementCardiac Fibrosis and Remodeling
Cited by 1,240
- Verified
Resting Heart Rate in Cardiovascular Disease
Fox, K., Borer, J. S., Camm, A. J., Danchin, N., Ferrari, R., Lopez Sendon, J. L., Steg, P. G., Tardif, J.-C., Tavazzi, L., & Tendera, M. (2007) · Journal of the American College of Cardiology
Heart rate and cardiovascular healthHeart Rate Variability and Autonomic Control
Cited by 1,062
- Verified
Cardiac-Resynchronization Therapy in Heart Failure with a Narrow QRS Complex
Ruschitzka, F., Abraham, W. T., Singh, J. P., Bax, J. J., Borer, J. S., Brugada, J., Dickstein, K., Ford, I., Gorcsan, J., Gras, D., et al. (2013) · New England Journal of Medicine
Cardiac pacing and defibrillation studiesHeart Failure Treatment and Management
Cited by 825
- Verified
The cardiovascular manifestations of the hypereosinophilic syndrome
Parrillo, J. E., Borer, J. S., Henry, W. L., Wolff, S. M., & Fauci, A. S. (1979) · The American Journal of Medicine
Eosinophilic Disorders and SyndromesAsthma and respiratory diseases
Cited by 314
- Verified
Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: results from the SHIFT echocardiography substudy
Tardif, J.-C., O'Meara, E., Komajda, M., Böhm, M., Borer, J. S., Ford, I., Tavazzi, L., & Swedberg, K. (2011) · European Heart Journal
Heart rate and cardiovascular healthHeart Failure Treatment and Management
Cited by 300
- Verified
Heart rate at baseline influences the effect of ivabradine on cardiovascular outcomes in chronic heart failure: analysis from the SHIFT study
Böhm, M., Borer, J., Ford, I., Gonzalez-Juanatey, J. R., Komajda, M., Lopez-Sendon, J., Reil, J.-C., Swedberg, K., & Tavazzi, L. (2013) · Clinical Research in Cardiology
Heart rate and cardiovascular healthHeart Failure Treatment and Management
Cited by 248
- Verified
Resting Heart Rate: Risk Indicator and Emerging Risk Factor in Cardiovascular Disease
Böhm, M., Reil, J.-C., Deedwania, P., Kim, J. B., & Borer, J. S. (2015) · The American Journal of Medicine
Heart rate and cardiovascular healthHeart Rate Variability and Autonomic Control
Cited by 236
- Verified
Cardiovascular Drug Development
Fordyce, C. B., Roe, M. T., Ahmad, T., Libby, P., Borer, J. S., Hiatt, W. R., Bristow, M. R., Packer, M., Wasserman, S. M., Braunstein, N., et al. (2015) · Journal of the American College of Cardiology
Pharmaceutical Economics and PolicyPharmaceutical industry and healthcare
Cited by 202
- Verified · note
The Funny Current: Cellular Basis for the Control of Heart Rate
DiFrancesco, D., & Borer, J. S. (2007) · Drugs
Cardiac electrophysiology and arrhythmiasIon channel regulation and function
Cited by 155
- Verified
Differential blood pressure effects of ibuprofen, naproxen, and celecoxib in patients with arthritis: the PRECISION-ABPM (Prospective Randomized Evaluation of Celecoxib Integrated Safety Versus Ibuprofen or Naproxen Ambulatory Blood Pressure Measurement) Trial
Ruschitzka, F., Borer, J. S., Krum, H., Flammer, A. J., Yeomans, N. D., Libby, P., Lüscher, T. F., Solomon, D. H., Husni, M. E., Graham, D. Y., et al. (2017) · European Heart Journal
Inflammatory mediators and NSAID effectsBlood Pressure and Hypertension Studies
Cited by 130
- Verified
Efficacy and safety of ivabradine in patients with chronic systolic heart failure and diabetes: an analysis from the SHIFT trial
Komajda, M., Tavazzi, L., Francq, B. G., Böhm, M., Borer, J. S., Ford, I., & Swedberg, K. (2015) · European Journal of Heart Failure
Heart rate and cardiovascular healthHeart Failure Treatment and Management
Cited by 76
- Verified
Comparison of Outcome Adjudication by Investigators and by a Central End Point Committee in Heart Failure Trials: Experience of the SHIFT Heart Failure Study
Tyl, B., Lopez Sendon, J., Borer, J. S., Lopez De Sa, E., Lerebours, G., Varin, C., De Montigny, A., Pannaux, M., & Komajda, M. (2020) · Circulation: Heart Failure
Heart Failure Treatment and ManagementStatistical Methods in Clinical Trials
Cited by 29
- Verified
Beneficial Effects of Ivabradine in Patients with Heart Failure, Low Ejection Fraction, and Heart Rate Above 77 b.p.m
Bouabdallaoui, N., O'Meara, E., Bernier, V., Komajda, M., Swedberg, K., Tavazzi, L., Borer, J. S., Bohm, M., Ford, I., & Tardif, J.-C. (2019) · ESC Heart Failure
Heart rate and cardiovascular healthHeart Failure Treatment and Management
Cited by 21
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free